Neurotechnology and wellness devices,
compared by evidence.

Nurosym is presented as a CE-marked non-invasive neuromodulation medical device in Europe. CE marking and intended use are regional regulatory facts; they are not equivalent to FDA approval or proof of every marketing claim.

Official guidance says not to use it after cervical vagotomy, with severe resting bradycardia, during pregnancy, or with metal or electronics near the tragus. Implanted devices, serious coronary disease or recent myocardial infarction, and pediatric use require professional supervision.

Expected tolerability issues include tingling, ear discomfort, irritation or redness. The manufacturer also lists temporary nausea, headache, confusion, malaise, or weakness; its adverse-event summary is manufacturer-reported, not an independent estimate of incidence.

Pulsetto states that the product is for general wellness and is not intended to diagnose, treat, cure, or prevent disease. Its program names may sound clinical, but they do not make it an authorized medical treatment.

The manufacturer advises against use with active implanted electronics, metal near the neck, simultaneous electrical stimulation, or certain cardiovascular and neurological histories. Pregnancy, pediatric use, cancer, abnormal neck anatomy, seizures, syncope, and recent myocardial infarction are also listed as unevaluated or contraindicated contexts.

Official guidance says stimulation should feel like mild tingling rather than pain and suggests reducing intensity or using one side if uncomfortable. Because the device stimulates the neck, uncertainty about rhythm disorders, blood pressure, implants, or seizures warrants clinician review before use.

Apollo explicitly describes the wearable as a consumer wellness device that is not FDA-approved to treat or cure a medical condition. ISO 13485 manufacturing language concerns quality systems, not clinical authorization or efficacy.

The device provides vibration rather than electrical stimulation. Official guidance says not to apply it over injured or irritated skin and to reduce intensity, loosen the strap, or move the device if wearing it is uncomfortable.

The product page advises keeping it more than 15 cm from medical devices. Users with implanted or body-worn medical electronics, significant symptoms, or a diagnosed condition should not treat a wellness claim as a substitute for professional care.

Sensate describes itself as a non-medical wellness device. Its CE mark is presented for electrical, safety, and emissions compliance; it is not a medical-device authorization for treating anxiety, PTSD, sleep disorders, or other diagnoses.

The manufacturer does not recommend use during pregnancy because it has not been specifically tested, and advises people with implanted electronic devices such as pacemakers not to use it. Adult use has much more documentation than pediatric use.

Sensate applies near-infrasound vibration to the sternum and pairs it with audio; it does not electrically stimulate the vagus nerve. Claims about “toning” or calming the nervous system should therefore be read as manufacturer positioning, not a verified neural target or clinical outcome.

The FDA instructions specify prescription use for adults 18 and older with a current moderate-to-severe major depressive episode, as monotherapy or adjunctive treatment, who are not treatment resistant. Treatment is intended under healthcare-provider supervision, even when sessions occur at home.

Do not use over open, broken, or damaged skin at electrode sites or with metallic skull reconstruction near the stimulation area. Pregnancy, suicidal thoughts, seizure history, cranial or brain implants, and significant scalp conditions require discussion with the treating clinician.

Commonly described effects are local dryness, redness, tingling, itching, stinging or burning and transient headache. Reused or dried pads increase burn risk; worsening depression, suicidality, or unexpected neurological symptoms require prompt clinical attention.

In the United States, Alpha-Stim AID is a prescription medical device cleared for anxiety and insomnia; depression authorization applies outside the US, not to the current US indication. Clearance establishes a legal indication, not guaranteed individual benefit.

Use is contraindicated with implanted pacemakers and implanted or wearable defibrillators. Safety has not been established during pregnancy, and official instructions warn against stimulation across the chest, directly over the eyes or carotid sinus, or near high-frequency surgical and shortwave equipment.

Reported adverse effects include dizziness, headache, skin irritation, and electrode burns. Users should not drive or operate hazardous equipment during treatment and, if affected, for several hours afterward; unexpected or persistent symptoms warrant professional review.

NeuroMyst states that Pro is a consumer wellness device, not a medical device, and is not intended to diagnose, treat, cure, or prevent a condition. Research use of the hardware does not turn retail presets into authorized treatments.

The manual says not to use it under age 18, during pregnancy, with a history of seizures, headache or migraine, or while intoxicated or incapacitated. Neurological impairment or an electronic medical implant requires physician consultation; electrodes should not cross the chest or contact wounded skin.

Expected effects include tingling, itching, redness, headache, sleepiness or sleeplessness, metallic taste, and visual flashes. Saline-soaked sponge preparation, hair clearance, electrode contact, polarity, current density, and montage selection materially affect both comfort and dose.

Muse S Athena is sold as a consumer mental-fitness, meditation, and sleep product rather than as a medical device for anxiety, depression, insomnia, cognitive impairment, or another diagnosis.

The headband measures electrical activity, blood oxygenation, pulse, and movement but does not deliver electrical brain stimulation. Scores, sleep stages, and app interpretations are consumer estimates and should not be used to diagnose a neurological, psychiatric, cardiovascular, or sleep disorder.

Practical risks center on fit, pressure, skin contact, sensor accuracy, battery care, and distraction from audio or screens. The legal guidance warns against heat, fire, crushing, and extreme pressure exposure of the lithium-ion battery; persistent skin or sleep problems warrant stopping use and seeking appropriate advice.

Biothm states that VNTune EZ and its other products are general-wellness products rather than medical devices and are not intended to diagnose, treat, cure, alleviate, or prevent a disease.

The product page provides placement and conductivity instructions but no substantive device-specific contraindication list for pregnancy, implanted electronics, cardiac rhythm disorders, seizure history, broken skin, or concurrent stimulation. That documentation gap is itself material for an electrical ear device.

Across taVNS research, ear pain, headache, and tingling are the most frequently reported events, but adverse-event reporting is incomplete and the review did not test Biothm. Users should stop painful stimulation and seek clinical guidance when implants, significant cardiovascular or neurological history, pregnancy, or unexplained symptoms are relevant.